CRL Annual Net Income
$474.62 M
-$11.60 M-2.39%
30 December 2023
Summary:
As of January 21, 2025, CRL annual net profit is $474.62 million, with the most recent change of -$11.60 million (-2.39%) on December 30, 2023. During the last 3 years, it has risen by +$110.32 million (+30.28%). CRL annual net income is now -2.39% below its all-time high of $486.23 million, reached on December 31, 2022.CRL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Net Income
$68.68 M
-$21.31 M-23.68%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly net profit is $68.68 million, with the most recent change of -$21.31 million (-23.68%) on September 28, 2024. Over the past year, it has dropped by -$118.41 million (-63.29%). CRL quarterly net income is now -63.35% below its all-time high of $187.41 million, reached on December 31, 2022.CRL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM Net Income
$413.08 M
-$18.71 M-4.33%
28 September 2024
Summary:
As of January 21, 2025, CRL TTM net profit is $413.08 million, with the most recent change of -$18.71 million (-4.33%) on September 28, 2024. Over the past year, it has dropped by -$61.54 million (-12.97%). CRL TTM net income is now -16.77% below its all-time high of $496.33 million, reached on March 1, 2023.CRL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.4% | -63.3% | -13.0% |
| 3 y3 years | +30.3% | -63.3% | -13.0% |
| 5 y5 years | +109.7% | -63.3% | -13.0% |
CRL Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.4% | +21.4% | -63.4% | +2.0% | -16.8% | +5.7% |
| 5 y | 5-year | -2.4% | +88.3% | -63.4% | +35.3% | -16.8% | +66.8% |
| alltime | all time | -2.4% | +190.9% | -63.4% | +110.4% | -16.8% | +173.3% |
Charles River Laboratories International Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $68.68 M(-23.7%) | $413.08 M(-4.3%) |
| June 2024 | - | $89.99 M(+33.7%) | $431.79 M(-1.6%) |
| Mar 2024 | - | $67.33 M(-64.0%) | $438.82 M(-7.5%) |
| Dec 2023 | $474.62 M(-2.4%) | $187.08 M(+114.1%) | $474.62 M(-0.1%) |
| Sept 2023 | - | $87.39 M(-9.9%) | $474.95 M(-1.9%) |
| June 2023 | - | $97.02 M(-5.9%) | $484.03 M(-2.5%) |
| Mar 2023 | - | $103.13 M(-45.0%) | $496.33 M(+2.1%) |
| Dec 2022 | $486.23 M(+24.4%) | $187.41 M(+94.3%) | $486.23 M(+11.4%) |
| Sept 2022 | - | $96.47 M(-11.8%) | $436.39 M(-1.6%) |
| June 2022 | - | $109.32 M(+17.5%) | $443.35 M(+4.9%) |
| Mar 2022 | - | $93.02 M(-32.4%) | $422.47 M(+8.1%) |
| Dec 2021 | $390.98 M(+7.3%) | $137.58 M(+33.0%) | $390.98 M(-1.4%) |
| Sept 2021 | - | $103.43 M(+16.9%) | $396.60 M(+0.1%) |
| June 2021 | - | $88.45 M(+43.7%) | $396.08 M(+5.6%) |
| Mar 2021 | - | $61.53 M(-57.0%) | $375.06 M(+3.0%) |
| Dec 2020 | $364.30 M(+44.6%) | $143.19 M(+39.1%) | $364.30 M(+20.8%) |
| Sept 2020 | - | $102.91 M(+52.6%) | $301.46 M(+11.1%) |
| June 2020 | - | $67.44 M(+32.8%) | $271.36 M(+9.6%) |
| Mar 2020 | - | $50.77 M(-36.8%) | $247.66 M(-1.7%) |
| Dec 2019 | $252.02 M(+11.3%) | $80.35 M(+10.4%) | $252.02 M(+8.9%) |
| Sept 2019 | - | $72.81 M(+66.5%) | $231.34 M(+5.7%) |
| June 2019 | - | $43.73 M(-20.7%) | $218.89 M(-4.4%) |
| Mar 2019 | - | $55.13 M(-7.6%) | $228.88 M(+1.1%) |
| Dec 2018 | $226.37 M(+83.5%) | $59.66 M(-1.2%) | $226.37 M(+65.4%) |
| Sept 2018 | - | $60.37 M(+12.4%) | $136.86 M(+6.1%) |
| June 2018 | - | $53.71 M(+2.0%) | $128.97 M(-0.2%) |
| Mar 2018 | - | $52.63 M(-276.3%) | $129.21 M(+4.7%) |
| Dec 2017 | $123.36 M(-20.3%) | -$29.85 M(-156.9%) | $123.36 M(-37.7%) |
| Sept 2017 | - | $52.47 M(-2.7%) | $197.88 M(+8.0%) |
| June 2017 | - | $53.95 M(+15.3%) | $183.15 M(+11.4%) |
| Mar 2017 | - | $46.78 M(+4.7%) | $164.40 M(+6.2%) |
| Dec 2016 | $154.76 M(+3.7%) | $44.68 M(+18.4%) | $154.76 M(+9.0%) |
| Sept 2016 | - | $37.73 M(+7.2%) | $141.97 M(+0.3%) |
| June 2016 | - | $35.21 M(-5.2%) | $141.61 M(-8.6%) |
| Mar 2016 | - | $37.14 M(+16.5%) | $154.91 M(+3.8%) |
| Dec 2015 | $149.31 M(+17.8%) | $31.88 M(-14.7%) | $149.31 M(+3.3%) |
| Sept 2015 | - | $37.38 M(-22.9%) | $144.59 M(+3.8%) |
| June 2015 | - | $48.51 M(+53.8%) | $139.25 M(+10.5%) |
| Mar 2015 | - | $31.54 M(+16.1%) | $126.01 M(-0.5%) |
| Dec 2014 | $126.70 M(+23.2%) | $27.17 M(-15.2%) | $126.70 M(+6.8%) |
| Sept 2014 | - | $32.04 M(-9.2%) | $118.63 M(+1.0%) |
| June 2014 | - | $35.26 M(+9.4%) | $117.46 M(+7.3%) |
| Mar 2014 | - | $32.23 M(+68.8%) | $109.48 M(+6.5%) |
| Dec 2013 | $102.83 M(+5.7%) | $19.10 M(-38.1%) | $102.83 M(+0.7%) |
| Sept 2013 | - | $30.87 M(+13.1%) | $102.14 M(+9.5%) |
| June 2013 | - | $27.28 M(+6.7%) | $93.25 M(-3.3%) |
| Mar 2013 | - | $25.58 M(+38.9%) | $96.43 M(-0.9%) |
| Dec 2012 | $97.30 M | $18.42 M(-16.2%) | $97.30 M(-8.2%) |
| Sept 2012 | - | $21.97 M(-27.9%) | $105.99 M(+3.1%) |
| June 2012 | - | $30.47 M(+15.2%) | $102.82 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $26.44 M(-2.5%) | $104.67 M(-4.5%) |
| Dec 2011 | $109.57 M(-132.5%) | $27.11 M(+44.2%) | $109.57 M(-142.0%) |
| Sept 2011 | - | $18.80 M(-41.8%) | -$261.11 M(-14.3%) |
| June 2011 | - | $32.32 M(+3.1%) | -$304.85 M(-5.5%) |
| Mar 2011 | - | $31.34 M(-109.1%) | -$322.72 M(-4.1%) |
| Dec 2010 | -$336.67 M(-394.2%) | -$343.56 M(+1277.5%) | -$336.67 M(-1476.2%) |
| Sept 2010 | - | -$24.94 M(-272.6%) | $24.46 M(-71.8%) |
| June 2010 | - | $14.45 M(-16.8%) | $86.72 M(-18.5%) |
| Mar 2010 | - | $17.38 M(-1.1%) | $106.42 M(-7.0%) |
| Dec 2009 | $114.44 M(-121.9%) | $17.57 M(-52.9%) | $114.44 M(-120.3%) |
| Sept 2009 | - | $37.31 M(+9.2%) | -$563.66 M(+1.5%) |
| June 2009 | - | $34.15 M(+34.4%) | -$555.49 M(+2.8%) |
| Mar 2009 | - | $25.41 M(-103.8%) | -$540.58 M(+3.6%) |
| Dec 2008 | -$521.84 M(-438.0%) | -$660.54 M(-1552.1%) | -$521.84 M(-397.2%) |
| Sept 2008 | - | $45.49 M(-7.3%) | $175.60 M(+1.6%) |
| June 2008 | - | $49.07 M(+11.2%) | $172.89 M(+6.9%) |
| Mar 2008 | - | $44.14 M(+19.6%) | $161.78 M(+4.8%) |
| Dec 2007 | $154.41 M(-376.8%) | $36.91 M(-13.7%) | $154.41 M(+1.1%) |
| Sept 2007 | - | $42.78 M(+12.7%) | $152.69 M(+63.6%) |
| June 2007 | - | $37.96 M(+3.2%) | $93.30 M(+15.1%) |
| Mar 2007 | - | $36.76 M(+4.5%) | $81.09 M(-245.4%) |
| Dec 2006 | -$55.78 M(-139.3%) | $35.19 M(-311.9%) | -$55.78 M(+37.6%) |
| Sept 2006 | - | -$16.61 M(-164.5%) | -$40.55 M(-599.1%) |
| June 2006 | - | $25.75 M(-125.7%) | $8.13 M(-42.9%) |
| Mar 2006 | - | -$100.11 M(-298.6%) | $14.24 M(-90.0%) |
| Dec 2005 | $142.00 M(+58.1%) | $50.42 M(+57.2%) | $142.00 M(+27.2%) |
| Sept 2005 | - | $32.07 M(+0.7%) | $111.66 M(+5.9%) |
| June 2005 | - | $31.86 M(+15.2%) | $105.41 M(+5.6%) |
| Mar 2005 | - | $27.65 M(+37.7%) | $99.85 M(+11.2%) |
| Dec 2004 | $89.79 M(+12.0%) | $20.08 M(-22.2%) | $89.79 M(-0.6%) |
| Sept 2004 | - | $25.82 M(-1.8%) | $90.36 M(+7.4%) |
| June 2004 | - | $26.30 M(+49.5%) | $84.13 M(+7.3%) |
| Mar 2004 | - | $17.59 M(-14.8%) | $78.39 M(-2.2%) |
| Dec 2003 | $80.15 M(+59.9%) | $20.64 M(+5.4%) | $80.15 M(+4.1%) |
| Sept 2003 | - | $19.59 M(-4.7%) | $77.01 M(+1.4%) |
| June 2003 | - | $20.56 M(+6.2%) | $75.95 M(+5.9%) |
| Mar 2003 | - | $19.35 M(+10.6%) | $71.72 M(+43.1%) |
| Dec 2002 | $50.13 M(+41.6%) | $17.50 M(-5.5%) | $50.13 M(+20.7%) |
| Sept 2002 | - | $18.53 M(+13.5%) | $41.54 M(+23.9%) |
| June 2002 | - | $16.33 M(-831.5%) | $33.53 M(+27.9%) |
| Mar 2002 | - | -$2.23 M(-125.0%) | $26.22 M(-25.9%) |
| Dec 2001 | $35.41 M(-415.5%) | $8.92 M(-15.2%) | $35.41 M(+14.5%) |
| Sept 2001 | - | $10.52 M(+16.7%) | $30.92 M(-899.9%) |
| June 2001 | - | $9.02 M(+29.7%) | -$3.87 M(-21.3%) |
| Mar 2001 | - | $6.95 M(+57.0%) | -$4.91 M(-56.3%) |
| Dec 2000 | -$11.22 M(-165.5%) | $4.43 M(-118.3%) | -$11.22 M(-28.3%) |
| Sept 2000 | - | -$24.26 M(-404.3%) | -$15.65 M(-281.8%) |
| June 2000 | - | $7.97 M(+1153.8%) | $8.61 M(+1253.8%) |
| Mar 2000 | - | $636.00 K | $636.00 K |
| Dec 1999 | $17.12 M(-26.8%) | - | - |
| Dec 1998 | $23.38 M | - | - |
FAQ
- What is Charles River Laboratories International annual net profit?
- What is the all time high annual net income for Charles River Laboratories International?
- What is Charles River Laboratories International annual net income year-on-year change?
- What is Charles River Laboratories International quarterly net profit?
- What is the all time high quarterly net income for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly net income year-on-year change?
- What is Charles River Laboratories International TTM net profit?
- What is the all time high TTM net income for Charles River Laboratories International?
- What is Charles River Laboratories International TTM net income year-on-year change?
What is Charles River Laboratories International annual net profit?
The current annual net income of CRL is $474.62 M
What is the all time high annual net income for Charles River Laboratories International?
Charles River Laboratories International all-time high annual net profit is $486.23 M
What is Charles River Laboratories International annual net income year-on-year change?
Over the past year, CRL annual net profit has changed by -$11.60 M (-2.39%)
What is Charles River Laboratories International quarterly net profit?
The current quarterly net income of CRL is $68.68 M
What is the all time high quarterly net income for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly net profit is $187.41 M
What is Charles River Laboratories International quarterly net income year-on-year change?
Over the past year, CRL quarterly net profit has changed by -$118.41 M (-63.29%)
What is Charles River Laboratories International TTM net profit?
The current TTM net income of CRL is $413.08 M
What is the all time high TTM net income for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM net profit is $496.33 M
What is Charles River Laboratories International TTM net income year-on-year change?
Over the past year, CRL TTM net profit has changed by -$61.54 M (-12.97%)